Sentara Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Norfolk Virginia United States (1888)

Organization Overview

First Clinical Trial
2002
NCT00161733
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Sentara Cancer Center | Sentara Norfolk General Hospital | Sentara Norfolk General Hospital, Norfolk, VA

Active Ingredients

Drugs in Phase 4 Trials (2)

fluorescein (1 trial)

tacrolimus (prograf) (1 trial)

Drugs in Phase 3 Trials (3)

human fibrin (Tisseel) (1 trial)

tamoxifen (nolvadex) (1 trial)

trastuzumab (herceptin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Neoplasms (Phase 4)

Breast Neoplasms (Phase 3)

Renal Insufficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5